NCT02883400
Spironolactone After Liver Transplant
See it on ClinicalTrials.gov ↗30 people
20%
80%
6 womenmiddle line = equal numbers24 men
- Phase
- PHASE4
- Paid for by
- Wake Forest University Health Sciences
- Finished
- 2018-01
- Health conditions
- Transplant, Liver
- Who could join
- Anyone
- Ages
- 18 Years – 75 Years
- Average age
- mean 55 years
- Age 65+
- 10%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 90% · Hispanic / Latina 6.7% · Black / African American 3.3%
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.